FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008730167> ?p ?o ?g. }

• W2008730167 endingPage "1823" @default.
• W2008730167 startingPage "1811" @default.
• W2008730167 abstract "Elevated levels of tumor necrosis factor-alpha (TNF-alpha) have been associated with several inflammatory diseases, and therefore, strategies for its suppression have become important targets in drug discovery. Our efforts to suppress TNF-alpha have centered on the inhibition of TNF-alpha converting enzyme (TACE) through the use of hydroxamate inhibitors. Starting from broad-spectrum matrix metalloproteinase (MMP) inhibitors, we have designed and synthesized novel benzothiadiazepines as potent and selective TACE inhibitors. The benzothiadiazepines were synthesized with variation in P1 and P1' in order to effect potency and selectivity. The inhibitors were evaluated versus porcine TACE (pTACE), and the initial selectivity was assessed with counterscreens of MMP-1, -2, and -9. Several potent and selective inhibitors were discovered with compound 41 being the most active against pTACE (K(i) = 5 nM) while still maintaining good selectivity versus the MMP's (at least 75-fold). Most compounds were assessed in the human peripheral blood mononuclear cell assay (PBMC) and the human whole blood assay (WBA) to determine their ability to suppress TNF-alpha. Compound 32 was the most potent compound in the PBMC assay (IC(50) = 0.35 microM), while compound 62 was the most active in the WBA (IC(50) = 1.4 microM)." @default.
• W2008730167 created "2016-06-24" @default.
• W2008730167 creator A5000577175 @default.
• W2008730167 creator A5003421053 @default.
• W2008730167 creator A5010486992 @default.
• W2008730167 creator A5012278873 @default.
• W2008730167 creator A5017672217 @default.
• W2008730167 creator A5018509246 @default.
• W2008730167 creator A5022643931 @default.
• W2008730167 creator A5025057940 @default.
• W2008730167 creator A5032923094 @default.
• W2008730167 creator A5041636907 @default.
• W2008730167 creator A5044857121 @default.
• W2008730167 creator A5064375039 @default.
• W2008730167 creator A5068506060 @default.
• W2008730167 creator A5079024504 @default.
• W2008730167 creator A5079303021 @default.
• W2008730167 creator A5083185937 @default.
• W2008730167 creator A5088197610 @default.
• W2008730167 creator A5091849244 @default.
• W2008730167 date "2003-04-02" @default.
• W2008730167 modified "2023-10-03" @default.
• W2008730167 title "Design, Synthesis, and Evaluation of Benzothiadiazepine Hydroxamates as Selective Tumor Necrosis Factor-α Converting Enzyme Inhibitors" @default.
• W2008730167 cites W1803185035 @default.
• W2008730167 cites W1964998566 @default.
• W2008730167 cites W1981148940 @default.
• W2008730167 cites W1994290003 @default.
• W2008730167 cites W1998491594 @default.
• W2008730167 cites W2025206744 @default.
• W2008730167 cites W2035505847 @default.
• W2008730167 cites W2041233605 @default.
• W2008730167 cites W2050243158 @default.
• W2008730167 cites W2055758035 @default.
• W2008730167 cites W2063461771 @default.
• W2008730167 cites W2064563647 @default.
• W2008730167 cites W2074881372 @default.
• W2008730167 cites W2077333548 @default.
• W2008730167 cites W2078301833 @default.
• W2008730167 cites W2079474526 @default.
• W2008730167 cites W2115211598 @default.
• W2008730167 cites W2154390735 @default.
• W2008730167 cites W2159692814 @default.
• W2008730167 cites W2328587823 @default.
• W2008730167 cites W2949429200 @default.
• W2008730167 doi "https://doi.org/10.1021/jm020475w" @default.
• W2008730167 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12723945" @default.
• W2008730167 hasPublicationYear "2003" @default.
• W2008730167 type Work @default.
• W2008730167 sameAs 2008730167 @default.
• W2008730167 citedByCount "58" @default.
• W2008730167 countsByYear W20087301672012 @default.
• W2008730167 countsByYear W20087301672013 @default.
• W2008730167 countsByYear W20087301672014 @default.
• W2008730167 countsByYear W20087301672015 @default.
• W2008730167 countsByYear W20087301672017 @default.
• W2008730167 countsByYear W20087301672018 @default.
• W2008730167 countsByYear W20087301672019 @default.
• W2008730167 countsByYear W20087301672020 @default.
• W2008730167 countsByYear W20087301672021 @default.
• W2008730167 countsByYear W20087301672022 @default.
• W2008730167 crossrefType "journal-article" @default.
• W2008730167 hasAuthorship W2008730167A5000577175 @default.
• W2008730167 hasAuthorship W2008730167A5003421053 @default.
• W2008730167 hasAuthorship W2008730167A5010486992 @default.
• W2008730167 hasAuthorship W2008730167A5012278873 @default.
• W2008730167 hasAuthorship W2008730167A5017672217 @default.
• W2008730167 hasAuthorship W2008730167A5018509246 @default.
• W2008730167 hasAuthorship W2008730167A5022643931 @default.
• W2008730167 hasAuthorship W2008730167A5025057940 @default.
• W2008730167 hasAuthorship W2008730167A5032923094 @default.
• W2008730167 hasAuthorship W2008730167A5041636907 @default.
• W2008730167 hasAuthorship W2008730167A5044857121 @default.
• W2008730167 hasAuthorship W2008730167A5064375039 @default.
• W2008730167 hasAuthorship W2008730167A5068506060 @default.
• W2008730167 hasAuthorship W2008730167A5079024504 @default.
• W2008730167 hasAuthorship W2008730167A5079303021 @default.
• W2008730167 hasAuthorship W2008730167A5083185937 @default.
• W2008730167 hasAuthorship W2008730167A5088197610 @default.
• W2008730167 hasAuthorship W2008730167A5091849244 @default.
• W2008730167 hasConcept C118792377 @default.
• W2008730167 hasConcept C137061746 @default.
• W2008730167 hasConcept C161790260 @default.
• W2008730167 hasConcept C17991360 @default.
• W2008730167 hasConcept C181199279 @default.
• W2008730167 hasConcept C185592680 @default.
• W2008730167 hasConcept C202751555 @default.
• W2008730167 hasConcept C203014093 @default.
• W2008730167 hasConcept C2775958869 @default.
• W2008730167 hasConcept C2776980637 @default.
• W2008730167 hasConcept C55493867 @default.
• W2008730167 hasConcept C57992300 @default.
• W2008730167 hasConcept C71924100 @default.
• W2008730167 hasConcept C98274493 @default.
• W2008730167 hasConceptScore W2008730167C118792377 @default.
• W2008730167 hasConceptScore W2008730167C137061746 @default.
• W2008730167 hasConceptScore W2008730167C161790260 @default.
• W2008730167 hasConceptScore W2008730167C17991360 @default.
• W2008730167 hasConceptScore W2008730167C181199279 @default.

• next